Melinta Therapeutics Highlighting Delafloxacin and ESKAPE

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Melinta Therapeutics Highlighting Delafloxacin and ESKAPE Candidates in Twelve Presentations at 2014 ICAAC Meeting

NEW HAVEN, Conn, Sept. 4, 2014 (GLOBE NEWSWIRE) -- Melinta Therapeutics today announced that an additional three abstracts have been accepted as late-breakers at the annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), an American Society for Microbiology meeting. Melinta and its collaborative investigators will thus be presenting a total of 10 posters and participating on two symposia at ICAAC. Eight posters will highlight delafloxacin , an investigational fluoroquinolone antibiotic with in vitro activity against both Gram positive and Gram negative pathogens, and two will provide details on RX‑P873, one of the Company's preclinical candidates from its ESKAPE Pathogen Program . The full list of abstracts and presentations follow.

September 6, 2014

  • * Pharmacokinetics of a 900 mg Oral Formulation of Delafloxacin (DLX) Healthy Subjects Supporting a Gonorrhea Phase 3 Study . Presentation A-056a. Session: Pharmacokinetics/Pharmacodynamics of Anti-Infective Agents. 12:00 - 2:00pm.
  • Evaluation of the Bactericidal Activity of Delafloxacin against Neisseria Gonorrhoeae Isolates by Time-Kill Methodology . Presentation F-283. Session: Topoisomerase Inhibitors: Quinolones and Much More. 12:00 - 2:00pm.
  • † Effects of Urine Matrix and pH on the Potency of Delafloxacin (DFX) and Ciprofloxacin (CIP) against Urogenic E. coli (EC) and K. pneumoniae (KP). Presentation F-275. Session: Topoisomerase Inhibitors: Quinolones and Much More. 12:00 - 2:00pm.

September 7, 2014

  • The Use of Ribosome Structure in the Rational Design of Novel Broad Spectrum Antibacterial Agents . Symposia: Quit Stalling! New Information on the Interaction of Antibiotics with the Bacterial Ribosome. 8:30 - 10:30am.
  • A Phase 1, Open-Label, Crossover Study to Determine the Effect of Food on the Pharmacokinetics of a Single Dose of Oral Delafloxacin (DLX) in Healthy Subjects . Presentation A-683. Session: Clinical Pharmacology of Anti-Infective Agents in Clinical Development. 11:00am - 1:00pm.
  • Pharmacokinetics and Relative Bioavailability of Intravenous and Oral Formulations of Delafloxacin (DLX) in Healthy Subjects . Presentation A-682. Session: Clinical Pharmacology of Anti-Infective Agents in Clinical Development. 11:00am - 1:00pm.

September 8, 2014

  • * Evaluation of the Potential for Delafloxacin Resistance Development in Neisseria gonorrhoeae . Presentation C-1412a. Session: Mycobacteria and Neisseria, the Re-Emerging Threats. 11:00am - 1:00pm.
  • * In vitro activity of RX-P873 tested against Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter spp . Presentation F-1555b. Session: Advances against Gram-Negative Pathogens. 11:00am - 1:00pm.
  • Evaluation of In Vitro Activity of Delafloxacin against Contemporary Neisseria Gonorrhoeae Isolates . Presentation C-1401. Session: Mycobacteria and Neisseria, the Re-Emerging Threats. 11:00am - 1:00pm.
  • Delafloxacin Exerts Potent Anti-gonococcal Activity despite Mutations that Decrease Antibiotic Susceptibility Due to Target Modification or Drug Efflux . Presentation C-1399. Session: Mycobacteria and Neisseria, the Re-Emerging Threats. 11:00am - 1:00pm.
  • In Vitro Activity of a Novel Antibacterial Agent (rx-p873) Against Gram-Negative Bacteria . Presentation C-1373. Session: Aminoglycosides and Newer Gram Negative Agents: Recent Insights. 11:00am - 1:00pm.
  • New Pyrrolocytosines: The RX-04 Program . Symposia: Progress on the Ribosome. 3:00 - 5:00pm.

NOTE: * denotes late-breaking abstracts and † denotes investigator-lead studies.

About Melinta Therapeutics

Melinta Therapeutics, Inc. is dedicated to the discovery, development and commercialization of groundbreaking antibiotics to overcome drug-resistant, life-threatening infections. The need for new therapies for drug-resistant infections is widely recognized as one of the most serious public health issues facing the world today. To meet this need, Melinta Therapeutics is rapidly progressing its late-stage investigational antibiotic, delafloxacin, which is currently in Phase 3 development for acute bacterial skin and skin structure infections (ABSSSI) and uncomplicated gonorrhea. Delafloxacin has been designated a qualified infectious disease product (QIDP) for both ABSSSI, uncomplicated gonorrhea and community-acquired bacterial pneumonia by the U.S. Food and Drug Administration. A key initiative at Melinta is to develop, through the application of Nobel Prize-winning science, a new class of antibiotics designed to overcome the drug-resistant ESKAPE pathogens known to cause serious hospital infections. Melinta Therapeutics is privately held and backed by lead investor Vatera Healthcare Partners among other private investors. The company is headquartered in New Haven, CT with offices in Lincolnshire, IL.

For more information, visit www.melinta.com .

Melinta Therapeutics Kathy Powell 312-724-9400 Media Contact Aline Schimmel 312-238-8957

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AppLovin Faces Legal Heat: Investors on Edge Today

Updated Category News Views 43

AppLovin's Day of Reckoning: Investors Take Note Ever find yourself caught in a whirlwind of corporate promises that slide into disappointment? Well, buckle up, because that's exactly where AppLovin finds itself today. They've stirred up a storm with investors over some questionable hyperbole about their artificial intelligence tools and ad services. Missteps and Market...

Continue Reading
Epic Legal Battle Yields $63M Verdict Against Chevron

Updated Category News Views 73

A David vs. Goliath Showdown in Court How's this for a courtroom drama? Picture eight lawyers taking on Chevron over a toxic pit buried beneath an unsuspecting family's home. These folks at Ernst Law Group and Trial Lawyers for Justice tackled Union Oil (now Chevron) and bagged a staggering $63 million for their client. This ain't your run-of-the-mill legal squabble; it's...

Continue Reading
Lululemon Faces Class Action over Alleged Missteps

Updated Category News Views 19

Trouble Brewing for Lululemon Y'ever get that gut feeling when something doesn't smell right? Well, Lululemon Athletica (NASDAQ: LULU) investors are probably feeling that now. A class action's kicking up dust over what some are saying was a downright bumpy ride. The brainiacs at Robbins LLP urge those who've lost bucks riding the LULU train to step forward ahead of the...

Continue Reading
Sulzer Rebuilds Petrocedeño Tower: A Milestone in Oil Revival

Updated Category News Views 223

Venezuela's Oil Infrastructure Gets a Crucial Boost No one said reviving a near-busted oil facility in Venezuela would be a walk in the park. But that's just what North American Blue Energy Partners (NABEP) is doing, handing the reins to Sulzer to rebuild a busted crude tower at the Petrocedeño upgrader. This ain't just another run-of-the-mill repair job; this is the...

Continue Reading
Sharon Stuart's Quest for Her Hidden Origins

Updated Category News Views 0

Delving Into Identity: A Personal Odyssey In a world where everyone seems to be searching for something, Sharon Stuart's quest is etched with the raw need to uncover her real origins. Abandoned as a newborn in the gritty streets of Oakland, she grew up grappling with looming questions about what made her who she is. Her journey is captured in her memoir, "Existing Without...

Continue Reading
Bizzdesign Tops Gartner’s 2026 Enterprise Architecture List

Updated Category News Views 108

Enterprise Architecture’s Silent Backbone Sometimes it's the quiet operators like Bizzdesign that hijack the spotlight after years of steady steering. With the latest nod from Gartner, Bizzdesign is clearly on a tear in the enterprise architecture domain. In their 2026 Critical Capabilities report, Bizzdesign's products—Horizzon, Alfabet, and Hopex—secured top spots...

Continue Reading
NaLA Pushes for Stronger Lifeline Fraud Measures

Updated Category News Views 14

Here's the thing about the Lifeline program: it's meant to be a lifeline, not a loophole for the crafty and unscrupulous. The National Lifeline Association (NaLA) is slamming the table, demanding that the Senate Commerce Committee put some real muscle into preventing fraud. Why the Urgency on Lifeline Fraud? NaLA’s got its sights on a more robust defensive line against...

Continue Reading
MoneyGram and Solflare Boost Crypto Cash-Out Options

Updated Category News Views 94

Crypto Meets Cash: A New Partnership in Money Movement Here's something to chew over your morning joe: MoneyGram's stepping up its game in the crypto world. They're pairing up with Solflare to let folks convert their USDC into hard cash across 170 countries and territories—no fees until New Year's Eve. It's like crypto's getting a passport to the physical world and not...

Continue Reading
ISC2 Launches AI Security Academy for Cyber Pros

Updated Category News Views 77

AI-Driven Threats Demand Expert Attention Every corner of the tech world has been blabbering about AI, but when it comes to cybersecurity, it's a whole different beast entirely. ISC2—a nonprofit that I like to think of as the cyber wizards’ guild—just threw a lifeline to cybersecurity folks who are swimming in the deep end of AI. With their shiny new AI Security...

Continue Reading
Lilly Endowment Boosts Military Families with $10M Grant

Updated Category News Views 20

A Game-Changer for Semper Fi & America's Fund Dive in, folks. What we've got here is a hefty chunk of change — $10 million to be precise — dropped into Semper Fi & America's Fund's lap by Lilly Endowment Inc. We're talking about a grant designed to shore up the long-term support system crafted for the brave souls in military families. It’s about time a significant...

Continue Reading

Top 5 Most Recently Viewed Articles

Homrich Berg Welcomes Tim Tallach as New Tax Director

Updated Category News Views 319

Homrich Berg Welcomes Tim Tallach as Director Atlanta-based Homrich Berg, a prominent fee-only wealth advisor recognized for its comprehensive services, proudly announces the addition of Tim Tallach, J.D., CPA, as its new Director of Advanced Tax Planning and Family Office Services. This important addition to the team aims to fortify the firm's capabilities in serving...

Continue Reading
G-III Apparel Group Schedules First Quarter Earnings Call

Updated Category News Views 168

G-III Apparel Group Prepares for Earnings Announcement G-III Apparel Group, Ltd. (NASDAQ: GIII) is a prominent entity in the global fashion industry, recognized for its innovative design, sourcing, and marketing capabilities. The company has recently made an announcement regarding its first quarter fiscal 2026 earnings. This significant event is scheduled to take place...

Continue Reading
Mediaplanet's Initiative to Empower Small Businesses Nationwide

Updated Category News Views 117

Mediaplanet's Campaign for Small Business Success Small businesses play a pivotal role in stimulating the economy by fostering innovation, generating employment, and enhancing community engagement. However, in the face of today's complex business challenges, many entrepreneurs require support to navigate these waters successfully. To address this need, Mediaplanet has...

Continue Reading
New Barclays Report Highlights AI's Impact on Data Centre Demand

Updated Category News Views 529

Revolutionizing Data Centres: Insights from Barclays Research In a groundbreaking report, Barclays Research reveals that the rising influence of artificial intelligence (AI) could propel data centre usage in the US to triple by 2030. This report, titled “AI revolution: Meeting massive AI infrastructure demands,” presents a comprehensive analysis of how AI's growth...

Continue Reading
Major Renovation Completed at Aloft Phoenix-Airport Hotel

Updated Category News Views 274

Aloft Phoenix-Airport Unveils Major Renovation In an exciting development for travelers, the Aloft Phoenix-Airport has completed a comprehensive renovation that significantly upgrades its facilities. This 143-room hotel, managed by HEI Hotels & Resorts and owned by The RADCO Companies, has refreshed everything from guest rooms to public spaces, ensuring a modern and...

Continue Reading